Skip to main content

Study 1: Effect of GBM-0009 on COVID-19 infection (Pilot Study)

Project Member(s): Hansbro, P.

Funding or Partner Organisation: Gertrude Biomedical Pty Ltd
Gertrude Biomedical Pty Ltd

Start year: 2021

Summary: Gertrude Biiomedical are an Australian based pharmaceutical company whose aim is to develope effective drugs that can combat diseases that are otherwise poorly treatable. They have asked us to test their drug GMB-0009 against SARS-CoV-2 infection in our mouse model

FOR Codes: Respiratory Diseases, Respiratory System and Diseases (incl. Asthma), Respiratory diseases , Clinical health